Enovis (ENOV) Research Hub

Enovis (ENOV) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 21.16 USD (+0.38%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.33, market cap 1.52B. This hub links to the full technical, earnings and options research available for ENOV.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNYSE, US
Last close21.16 USD (+0.38%)
52-week range16.7 USD – 31.67 USD
Trend regimeRange
14-day RSI73.3 (Overbought)
Trailing P/E-1.33
Market cap1.52B
Dividend yield0.00%
Next earnings2026-08-06

Available research for ENOV

Earnings

ENOV earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -1.33. Updated 2026-07-23.

Options: Covered Call

Covered Call on ENOV: how it works, illustrative setup around the real 21.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on ENOV: how it works, illustrative setup around the real 21.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on ENOV: how it works, illustrative setup around the real 21.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

ENOV technical analysis: range, last 21.16 USD, RSI 73.3, 52w range 16.7 USD–31.67 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is ENOV in?

Enovis (ENOV) is classified under Healthcare (Medical - Devices), listed on NYSE, US.

Is ENOV in an uptrend or downtrend?

As of 2026-10-26, ENOV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is ENOV's trailing P/E ratio?

ENOV's trailing P/E is -1.33, with a market cap of 1.52B. See the earnings research page for full valuation detail.

When does ENOV next report earnings?

ENOV is next scheduled to report earnings on 2026-08-06.